Genocea Biosciences, Inc. (GNCAQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 21, 2025, 9:30 AM EST
Genocea Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
Cash & Equivalents | 20.14 | 37.15 | 79.77 | 40.13 | 26.36 | 12.27 | Upgrade
|
Cash & Short-Term Investments | 20.14 | 37.15 | 79.77 | 40.13 | 26.36 | 12.27 | Upgrade
|
Cash Growth | -69.51% | -53.43% | 98.79% | 52.22% | 114.79% | -80.63% | Upgrade
|
Prepaid Expenses | 4.27 | 4.67 | 2.46 | 1.46 | 0.7 | 0.81 | Upgrade
|
Total Current Assets | 24.41 | 41.82 | 82.23 | 41.58 | 27.06 | 13.08 | Upgrade
|
Property, Plant & Equipment | 13.5 | 13.26 | 14.43 | 8.92 | 2.58 | 3.46 | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | - | 0.57 | Upgrade
|
Other Long-Term Assets | 0.88 | 0.88 | 1.84 | 2.1 | 1.48 | 0.38 | Upgrade
|
Total Assets | 38.79 | 55.97 | 98.49 | 52.61 | 31.12 | 17.49 | Upgrade
|
Accounts Payable | 0.59 | 0.5 | 0.53 | 0.55 | 1.66 | 3.52 | Upgrade
|
Accrued Expenses | 7.55 | 8.25 | 5.37 | 3.85 | 2.91 | 4.72 | Upgrade
|
Current Portion of Long-Term Debt | 4.7 | 4.64 | 13.86 | - | 5.26 | 6.66 | Upgrade
|
Current Portion of Leases | 2.41 | 2.35 | 1.61 | 1.12 | - | - | Upgrade
|
Current Unearned Revenue | 1.56 | 1.7 | 1.64 | - | - | - | Upgrade
|
Other Current Liabilities | 1.21 | 1.25 | 1.97 | 0.76 | 0.91 | 0.89 | Upgrade
|
Total Current Liabilities | 18.03 | 18.68 | 25 | 6.28 | 10.73 | 15.78 | Upgrade
|
Long-Term Debt | 2.95 | 4.15 | - | 13.41 | 9.57 | 7.65 | Upgrade
|
Long-Term Leases | 5.43 | 6.05 | 8.4 | 5.4 | - | - | Upgrade
|
Other Long-Term Liabilities | - | 0.01 | 56.12 | 2.49 | 3.48 | 0.11 | Upgrade
|
Total Liabilities | 26.4 | 28.89 | 89.51 | 27.57 | 23.78 | 23.54 | Upgrade
|
Common Stock | 0.06 | 0.06 | 0.05 | 0.03 | 0.01 | 0.03 | Upgrade
|
Additional Paid-In Capital | 436.17 | 434.88 | 383.6 | 355.27 | 298.63 | 258.11 | Upgrade
|
Retained Earnings | -423.84 | -407.86 | -374.67 | -330.95 | -292 | -264.19 | Upgrade
|
Total Common Equity | 12.39 | 27.08 | 8.98 | 24.34 | 6.63 | -6.05 | Upgrade
|
Shareholders' Equity | 12.39 | 27.08 | 8.98 | 25.04 | 7.34 | -6.05 | Upgrade
|
Total Liabilities & Equity | 38.79 | 55.97 | 98.49 | 52.61 | 31.12 | 17.49 | Upgrade
|
Total Debt | 15.49 | 17.19 | 23.87 | 19.92 | 14.82 | 14.31 | Upgrade
|
Net Cash (Debt) | 4.65 | 19.96 | 55.9 | 20.21 | 11.54 | -2.04 | Upgrade
|
Net Cash Growth | -89.97% | -64.28% | 176.60% | 75.13% | - | - | Upgrade
|
Net Cash Per Share | 0.07 | 0.29 | 1.20 | 0.98 | 1.12 | -0.57 | Upgrade
|
Filing Date Shares Outstanding | 58.78 | 58.73 | 53.52 | 27.64 | 14.05 | 3.59 | Upgrade
|
Total Common Shares Outstanding | 58.73 | 58.23 | 53.02 | 27.45 | 10.85 | 3.59 | Upgrade
|
Working Capital | 6.38 | 23.14 | 57.23 | 35.3 | 16.33 | -2.7 | Upgrade
|
Book Value Per Share | 0.21 | 0.47 | 0.17 | 0.89 | 0.61 | -1.69 | Upgrade
|
Tangible Book Value | 12.39 | 27.08 | 8.98 | 24.34 | 6.63 | -6.05 | Upgrade
|
Tangible Book Value Per Share | 0.21 | 0.47 | 0.17 | 0.89 | 0.61 | -1.69 | Upgrade
|
Machinery | - | 6.26 | 5.27 | 4.92 | 4.55 | 4.53 | Upgrade
|
Construction In Progress | - | 0.45 | 0.61 | 0.1 | - | - | Upgrade
|
Leasehold Improvements | - | 1.41 | 3.27 | 1.52 | 1.52 | 1.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.